HPMC film forming serums are regulated as cosmetics in both the US and the EU, but the compliance frameworks differ substantially and affect how you structure labeling, safety documentation, and your manufacturing partner selection.
In the United States, the FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FD&C Act) as amended by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Under MoCRA, cosmetic facilities must register with the FDA (manufacturer and responsible party), products must be listed, and serious adverse event reporting is mandatory. HPMC itself is not restricted; however, any active ingredients that make drug-like claims (e.g., "reduces wrinkles by stimulating collagen production" could be interpreted as a drug claim) risk reclassifying the product as an OTC drug, which carries a far heavier regulatory burden. Keep your label claims in the cosmetic lane — describe appearance changes, not biological mechanisms.
For California specifically, Prop 65 requires a warning if the product contains any listed chemicals above threshold concentrations. Common fragrance components (coumarin, lilial — now EU-banned) and certain preservatives (formaldehyde-releasing agents) can trigger Prop 65 requirements. Work with your cosmetic chemist to screen the formula against the Prop 65 list before finalizing.
In the European Union, Regulation 1223/2009 governs cosmetics. Key requirements include: a Product Information File (PIF) maintained by the Responsible Person (RP) established in the EU; a cosmetic product safety report (CPSR) signed by a qualified safety assessor; notification in the Cosmetic Products Notification Portal (CPNP) before placing on market; full INCI labeling on pack; and compliance with Annexes II (prohibited), III (restricted), IV (colorants), V (preservatives), and VI (UV filters). HPMC is unrestricted in the EU. Several fragrance allergens require labeling above 0.001% (leave-on) or 0.01% (rinse-off) per the 2023 updated Annex III.
China (NMPA) has its own registration regime for imported cosmetics, including mandatory animal testing in some categories (though this is evolving). If China is a target market, begin that regulatory process in parallel — it can take 12–18 months.
Make sure your contract manufacturer can supply the documentation your regulatory pathway requires: COA, microbial testing results, stability data, safety assessment support, and INCI declarations. Not every low-MOQ lab can do this — it is a legitimate differentiator when vetting partners.
Read the full guide on Private Label HPMC Film Forming Serum Manufacturer Low MOQ →